GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ouro Fino Saude Animal Participacoes SA (BSP:OFSA3) » Definitions » Equity-to-Asset

Ouro Finoude Animal Participacoes (BSP:OFSA3) Equity-to-Asset : 0.54 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Ouro Finoude Animal Participacoes Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ouro Finoude Animal Participacoes's Total Stockholders Equity for the quarter that ended in Dec. 2023 was R$689.4 Mil. Ouro Finoude Animal Participacoes's Total Assets for the quarter that ended in Dec. 2023 was R$1,279.0 Mil. Therefore, Ouro Finoude Animal Participacoes's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.54.

The historical rank and industry rank for Ouro Finoude Animal Participacoes's Equity-to-Asset or its related term are showing as below:

BSP:OFSA3' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.49   Med: 0.54   Max: 0.57
Current: 0.54

During the past 10 years, the highest Equity to Asset Ratio of Ouro Finoude Animal Participacoes was 0.57. The lowest was 0.49. And the median was 0.54.

BSP:OFSA3's Equity-to-Asset is ranked worse than
55.51% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs BSP:OFSA3: 0.54

Ouro Finoude Animal Participacoes Equity-to-Asset Historical Data

The historical data trend for Ouro Finoude Animal Participacoes's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ouro Finoude Animal Participacoes Equity-to-Asset Chart

Ouro Finoude Animal Participacoes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.57 0.51 0.54 0.55 0.54

Ouro Finoude Animal Participacoes Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.56 0.51 0.53 0.54

Competitive Comparison of Ouro Finoude Animal Participacoes's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Ouro Finoude Animal Participacoes's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ouro Finoude Animal Participacoes's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ouro Finoude Animal Participacoes's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Ouro Finoude Animal Participacoes's Equity-to-Asset falls into.



Ouro Finoude Animal Participacoes Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Ouro Finoude Animal Participacoes's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=689.374/1279.009
=0.54

Ouro Finoude Animal Participacoes's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=689.374/1279.009
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ouro Finoude Animal Participacoes  (BSP:OFSA3) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Ouro Finoude Animal Participacoes Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Ouro Finoude Animal Participacoes's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Ouro Finoude Animal Participacoes (BSP:OFSA3) Business Description

Traded in Other Exchanges
N/A
Address
Anhanguera Highway SP 330, Km 298, Industrial District, Cravinhos, SP, BRA, 14140-000
Ouro Fino Saude Animal Participacoes SA is engaged in the production and sale of veterinary drugs, vaccines, and other products for cattle, pigs, poultry, sheep, horses and goats and pets. The company reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimicrobials, Biological, Ectoparasiticides, Endectocides, Fortifiers / Supplements, and others.

Ouro Finoude Animal Participacoes (BSP:OFSA3) Headlines

No Headlines